Metastatic Breast Cancer Patient Input Regarding Clinical Trial Endpoints: Update on Research Advocacy Network Survey REGISTER HERE! Endpoints for clinical trials studying metastatic breast cancer (MBC), in particular the patient perspective, has been the subject of much discussion in recent years. In 2017, the Research Advocacy Network (RAN) conducted focus groups with patients with MBC […]
On Wednesday, July 25 at 12:30 PM Eastern, the MBC Alliance will host our member organization, BreastCancerTrials.org, for an overview of their exciting new offering for MBC patients as well as their families and friends: Metastatic Trial Talk. Elly Cohen and Susan Colen will give us an overview of the new companion application to the […]
Some breast cancers are thought to be hereditary, caused by abnormal genes passed from parent to child. Most cases of hereditary breast cancer are associated with inherited mutations in two genes: BRCA1 (BReast CAncer gene one) and BRCA2 (BReast CAncer gene two). Together BRCA1 and BRCA2 mutations account for about 25 to 30 percent of […]
The Black Wo(Men) Speak Symposium was initiated as a response to the BECOME (Black Experience of Clinical Trials and Opportunities for Meaningful Engagement) survey conducted by the Metastatic Breast Cancer Alliance (MBCA) which found that 8 out of 10 Black people living with metastatic breast cancer would consider participating in clinical trials, but that only […]
Register now for this webinar and learn more about what palliative care is (and isn't) in this enlightening talk with Cal Cates, Executive Director of Healwell. This event will be co-hosted by Sue Weldon (CEO & Founder of Alliance nonprofit organization member Unite for HER) and Barbara Bigelow (Patient/Advocate member of the Alliance.) REGISTER HERE!
